Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1996-07-09
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, 546256, 5462687, 5462694, 546289, 546308, A61K 3144, C07D41704
Patent
active
055345280
ABSTRACT:
The present invention relates to therapeutically active azacyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
REFERENCES:
patent: 5041455 (1991-08-01), Sauerberg et al.
patent: 5043345 (1991-08-01), Sauerberg et al.
Tune et al "Auticholinergic delirium caused by topical hematropine ophthalmologic solution" Index medicine 330504 (1992).
Wilbraham et al "Organic and biological chemistry" Benjamin/Cumming Publisher, pp. 268-269 (1985).
Sugrue "The Pharmacology of antiglaucoma drug" Pharm Ther 43 91-138 (1989).
Bodor et al "Improved delivery through biological membrane" J. Med. Chem. 31 100-106 (1988).
Webster's II Dictionary Reverside Publishing, 1984, p. 854.
Olesen Preben H.
Sauerberg Per
Chang Ceila
Lambiris Elias J.
Novo Nordisk A S
Zelson Steve T.
LandOfFree
Thiadiazolyl tetrhydrpyridines for treating glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiadiazolyl tetrhydrpyridines for treating glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiadiazolyl tetrhydrpyridines for treating glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1867460